Metraipolis › archive › dc_4bd2f88c5487

Telitacicept for the treatment of Sjögren's disease complicated by unilateral vocal fold immobility, severe hypergammaglobulinemia, and diabetes: a case report — Europe PMC PMID:42952743

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42952743
DOI
10.3389/fimmu.2026.1956268
License (as archived)
solo-consultazione
Archived
2026-10-31T21:22:17.040Z
SHA-256 of the archived text
a1af1312c5b8ebe8ab58165211b50b36aa30299c8b9948a2c8de01e79dae13b8
Stable URL of this page
https://metraipolis.com/documento/dc_4bd2f88c5487

How to cite

Telitacicept for the treatment of Sjögren's disease complicated by unilateral vocal fold immobility, severe hypergammaglobulinemia, and diabetes: a case report — Europe PMC PMID:42952743 — Europe PMC (en), https://europepmc.org/article/MED/42952743 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bd2f88c5487 (Metraipolis archive dc_4bd2f88c5487, sha256 a1af1312c5b8ebe8ab58165211b50b36aa30299c8b9948a2c8de01e79dae13b8)
BibTeX
@misc{dc4bd2f88c5487,
  title = {Telitacicept for the treatment of Sjögren's disease complicated by unilateral vocal fold immobility, severe hypergammaglobulinemia, and diabetes: a case report — Europe PMC PMID:42952743},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42952743},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bd2f88c5487; sha256 a1af1312c5b8ebe8ab58165211b50b36aa30299c8b9948a2c8de01e79dae13b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42952743. Agents can read the archived copy with the MCP tool read_document.